{"transactions":[{"id":4629710,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2026-10-05T20:04:47.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."}],"balance_after":2125,"source":{"system":"sec-edgar","filing":"0001836301-26-000020","document":"wk-form4_1791230684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836301/000183630126000020/wk-form4_1791230684.xml","form_type":"4"}},{"id":695044,"issuer":{"id":1656,"kind":"organization","name":"Honeywell Aerospace Inc.","symbol":"HONA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-08-05T23:35:48.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Instrument converts to Issuer's Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units shall vest on April 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units shall vest on April 15, 2027."}],"balance_after":572,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":572},"source":{"system":"sec-edgar","filing":"0001628280-26-053683","document":"wk-form4_1785972946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836301/000162828026053683/wk-form4_1785972946.xml","form_type":"4"}},{"id":720571,"issuer":{"id":1656,"kind":"organization","name":"Honeywell Aerospace Inc.","symbol":"HONA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Compensation (Phantom Shares)","published_at":"2026-07-02T00:29:18.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":135.1441,"price":226.24,"value":30575.001184,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Deferred Compensation (Phantom Shares) are allocated based on the price of common stock, par value $0.01 per share (\"HONA Common Stock\"), of Honeywell Aerospace Inc., a Delaware corporation (\"HONA\") on the contribution date by dividing the dollar amount of the contribution by the price per share of HONA Common Stock. HONA Common Stock prices are based on the mean of the highest and lowest sales price on the date of contribution. Phantom Shares are settled in cash based on the price of HONA Common Stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are accrued under the Deferred Compensation Plan for Non-Employee Directors and will be settled in cash based on elections by the Reporting Person as permitted under the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom shares are accrued under the Deferred Compensation Plan for Non-Employee Directors and will be settled in cash based on elections by the Reporting Person as permitted under the Plan."}],"balance_after":135.1441,"derivative":{"underlying":"Common Stock","underlying_shares":135.1441},"source":{"system":"sec-edgar","filing":"0001628280-26-046678","document":"wk-form4_1782952155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836301/000162828026046678/wk-form4_1782952155.xml","form_type":"4"}},{"id":732680,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2026-06-18T20:11:57.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."}],"balance_after":1581,"source":{"system":"sec-edgar","filing":"0001836301-26-000016","document":"wk-form4_1781813514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000183630126000016/wk-form4_1781813514.xml","form_type":"4"}},{"id":747405,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:39:59.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001836301-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000183630126000014/primarydocument.xml","form_type":"4"}},{"id":791589,"issuer":{"id":3075,"kind":"organization","name":"MSCI Inc.","symbol":"MSCI"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T20:05:37.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units vesting on May 1, 2027."}],"balance_after":1059,"source":{"system":"sec-edgar","filing":"0001836301-26-000012","document":"wk-form4_1778011531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408198/000183630126000012/wk-form4_1778011531.xml","form_type":"4"}},{"id":817498,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2026-04-03T20:05:33.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."}],"balance_after":994,"source":{"system":"sec-edgar","filing":"0001836301-26-000009","document":"wk-form4_1775246728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000183630126000009/wk-form4_1775246728.xml","form_type":"4"}},{"id":880355,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2026-02-26T21:36:36.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."}],"balance_after":273,"source":{"system":"sec-edgar","filing":"0001836301-26-000006","document":"wk-form4_1772141793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000183630126000006/wk-form4_1772141793.xml","form_type":"4"}},{"id":1117317,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:39:07.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004641","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218025004641/primarydocument.xml","form_type":"4"}},{"id":1159019,"issuer":{"id":3075,"kind":"organization","name":"MSCI Inc.","symbol":"MSCI"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:05:12.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units vesting on May 1, 2026."}],"balance_after":671,"source":{"system":"sec-edgar","filing":"0001408198-25-000142","document":"wk-form4_1746475503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408198/000140819825000142/wk-form4_1746475503.xml","form_type":"4"}},{"id":1438701,"issuer":{"id":3075,"kind":"organization","name":"MSCI Inc.","symbol":"MSCI"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-07T20:07:51.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units vesting on May 1, 2025."}],"balance_after":286,"source":{"system":"sec-edgar","filing":"0001408198-24-000145","document":"wk-form4_1723061264.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408198/000140819824000145/wk-form4_1723061264.xml","form_type":"4"}},{"id":1454383,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:12:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005720","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218024005720/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1486026,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:22:17.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":54278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":54278,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":54278},"source":{"system":"sec-edgar","filing":"0001562180-24-004842","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218024004842/primarydocument.xml","form_type":"4"}},{"id":1859943,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:34:07.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 8, 2024 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 8, 2023."}],"balance_after":65000,"derivative":{"exercise_price":6.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-23-005029","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218023005029/primarydocument.xml","form_type":"4"}},{"id":2238595,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T22:37:34.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2023 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 6, 2022."}],"balance_after":65000,"derivative":{"exercise_price":4.95,"expiration_date":"2032-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-22-004944","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000156218022004944/primarydocument.xml","form_type":"4"}},{"id":2848634,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T23:54:39.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":11795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in full on February 3, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired."}],"balance_after":11795,"derivative":{"exercise_price":25,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":11795},"source":{"system":"sec-edgar","filing":"0000899243-21-007184","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000089924321007184/doc4a.xml","form_type":"4/A","original_submission_date":"2021-02-05"}},{"id":2876233,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":26108,"kind":"person","name":"Seitz Michelle","position":1,"cik":"0001836301","reported_name":"Seitz Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-05T22:15:46.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on February 3, 2022."}],"balance_after":7000,"derivative":{"exercise_price":25,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-21-005069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770121/000089924321005069/doc4.xml","form_type":"4"}}]}